Saturday, November 2, 2024
Facebook Linkedin Twitter
HomeTagsPrecigen

Precigen

Biotechnology

Precigen Focuses Portfolio on Upcoming Gene Therapy Launch

News Desk -
Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced a strategic...
Biotechnology

Precigen Regains Exclusive Rights to Proven CAR-T Targets, CD19 and BCMA, to Enable Unencumbered Development and Commercialization of UltraCAR-T

News Desk -
Precigen, Inc, a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced the amendment...
Biotechnology

Precigen Completes Sale of Non-Healthcare Subsidiary Trans Ova Genetics

PR Newswire -
Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced that the...
Biotechnology

Precigen Enters into Agreement to Divest Non-Healthcare Subsidiary Trans Ova Genetics

PR Newswire -
Precigen, Inc., a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, announced that the...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us